What the work includes
These are the components that decide review depth and acceptance. The brief should name each one up front.
- Clinical trial documentation
- Translation of protocols, informed consent forms (ICFs), case report forms (CRFs), clinical study reports (CSRs), and patient-reported outcome (PRO) instruments. Domain-matched linguists with clinical trial experience handle regulatory terminology. Back-translation and reconciliation workflows available for linguistic validation.
- IFU and medical device labeling
- For instructions for use, package inserts, safety data sheets and device labeling, identify the product, destination market, document type and applicable submission requirements in the brief. Agree terminology, review and format against those requirements, with change-controlled updates across language versions; the responsible applicant determines regulatory release.
- Regulatory submission translation
- Regulatory dossiers, CTD modules, and submission packages translated for FDA, EMA, PMDA, and national competent authorities. Formatting preserved. Cross-reference consistency maintained across documents within a submission.
- Patient-facing content
- Patient education materials, health literacy content, discharge instructions, and public health documentation. Readability-appropriate translation that preserves clinical accuracy while meeting plain-language requirements.
- Pharmacovigilance reporting
- Adverse event narratives, periodic safety update reports (PSURs), and safety signal documentation. Translated with medical terminology precision and regulatory formatting requirements intact. Turnaround aligned to pharmacovigilance reporting deadlines.